Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Conditions:   COVID-19 Infection;   COVID-19 Vaccine Adverse Reaction Interventions:   Biological: LEM-mR203;   Biological: Placebo Sponsor:   Lemonex Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials